← Leaderboards
Alexander Emmanuelli
Weill Medical Coll Of Cornell Univ
$140,482
Attributed
$140,482
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$140,482 · 1
By mechanism
F31$140,482 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Lukas Edward Dow$10,323,278
- Juan R Cubillos-Ruiz$3,263,772
- David Artis$33,334,671
- Robert M Samstein$4,654,145
- Nicholas J. Bessman$3,357,748
Others in their field
Other Emerging Leaders on “Flow Cytometry”
- Prasant Mohapatra · University Of California At Davis$53,606,662
- Thomas Denny · Duke University$22,999,550
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$10,343,043
- Jacob D Estes · Oregon Health & Science University$9,339,444
- Anthony J St Leger · University Of Pittsburgh At Pittsburgh$7,131,059
Research focus
Flow CytometryAblationAnti-CancerAdaptive ImmunityArginineAmino AcidsBinding SitesCancer ControlCancer ImmunotherapyArginaseCancer RecurrenceCell PhysiologyCellsChemotherapyComplexConditional KnockoutCytokineCytotoxicDrug ResistanceEffective TherapyEffector T CellEndoplasmic ReticulumEndoplasmic Reticulum StressFunctional Disorder
Grant awards (3)
Immunosuppressive Programs Driven by IRE1 signaling in ovarian cancer$47,694
F31 · FY2023 · CA · contact PI
Immunosuppressive Programs Driven by IRE1 signaling in ovarian cancer$46,752
F31 · FY2022 · CA · contact PI
Immunosuppressive Programs Driven by IRE1 signaling in ovarian cancer$46,036
F31 · FY2021 · CA · contact PI